Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Lancet Respir Med. 2020 May;8(5):482–492. doi: 10.1016/S2213-2600(20)30011-4

Table 3. Effect sizes (beta), 95% confidence intervals (CI), and P-values for five core SNPs and expression of the eight 17q12–21 genes that are expressed in PBMCs (A) and upper airway epithelial cells (B).

The effect sizes (beta) reflect the expected increase in expression associated with each copy of the asthma risk allele. P-values were corrected for 40 tests (5 SNPs x 8 genes); P < 0.0012 are considered significant (shown in bolded font) (also see Figure 2).

A. PBMCs (n=85)
SNP PGAP3 ERBB2 MIEN1 GRB7
Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value

rs12936231 1·00 0·96, 1·041 0·81 0·976 0·91, 1·037 0·55 0·994 0·96, 1·024 0·99 1·02 0·82, 1·25 0·70
rs2305480 1·01 0·95, 1·084 0·62 1.0 0·89, 1·11 0·91 0·987 0·93, 1·040 0·68 0·973 0·67, 1·40 0·92
rs7216389 0·98 0·93, 1·042 0·55 0·945 0·86, 1·036 0·32 0·993 0·95, 1·038 0·90 0·888 0·65, 1·21 0·53
rs4065275 0·98 0·95, 1·026 0·49 0·992 0·93, 1·057 0·96 1·008 0·97, 1·039 0·39 1·032 0·83, 1·27 0·61
rs8076131 1·00 0·95, 1·064 0·84 0·942 0·85, 1·033 0·28 0·99 0·94, 1·035 0·8 0·943 0·69, 1·29 0·78

SNP IKZF3 GSDMB ORMDL3 GSDMA
Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value

rs12936231 0·967 0·91, 1·027 0·52 1·238 1·15, 1·32 <0.0001 1·186 1·12, 1·24 <0.0001 1·202 0·91, 1·58 0·23
rs2305480 0·938 0·84, 1·045 0·27 1·218 1·067, 1·39 0.0025 1·232 1·11, 1·35 <0.0001 1·279 0·78, 2·094 0·33
rs7216389 0·915 0·83, 1·001 0·17 1·239 1·11, 1·38 0.0004 1·203 1·10, 1·30 <0.0001 1·279 0·84, 1·93 0·32
rs4065275 1·003 0·94, 1·068 0·44 1·185 1·10, 1·27 <0.0001 1·133 1·071, 1·19 <0.0001 1·067 0·80, 1·42 0·79
rs8076131 0·94 0·85, 1·029 0·38 1·158 1·034, 1·29 0·021 1·151 1·058, 1·25 0.0026 1·408 0·92, 2·13 0·14

B. Upper Airway Epithelial Cells (n=246)
SNP PGAP3 ERBB2 MIEN1 GRB7
Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value

rs12936231 1·026 0·989, 1·064 0·17 0·993 0·970, 1·016 0·54 1·009 0.993, 1.025 0·25 0·949 0.899, 1.002 0·061
rs2305480 1·147 1.081, 1.216 <0.0001 1·031 0.992, 1.071 0·12 1·016 0.991, 1.042 0·22 0·980 0.895, 1.074 0·67
rs7216389 1·081 1.032, 1.133 0.0010 1·028 0.998, 1.060 0·070 1·018 0.998, 1.039 0·070 0·990 0.921, 1.064 0·78
rs4065275 1·034 0.997, 1.072 0·74 1·008 0.985, 1.032 0·49 1·003 0.988, 1.019 0·67 1·003 0.949, 1.060 0·93
rs8076131 1·107 1.052, 1.164 <0.0001 1·028 0.995, 1.063 0·093 1·014 0.993, 1.036 0·20 0·971 0.898, 1.050 0·46

SNP IKZF3 GSDMB ORMDL3 GSDMA
Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value Beta 95% CI P-value

rs12936231 0·872 0.799, 0.951 0.0021 1·026 0.975, 1.080 0·32 0·989 0.962, 1.017 0·45 0·908 0.741, 1.112 0·35
rs2305480 0·976 0.850, 1.119 0·73 1·353 1.251, 1.464 <0.0001 0·990 0.945, 1.036 0·66 1·275 0.911, 1.785 0·16
rs7216389 0·971 0.874, 1.078 0·58 1·144 1.073, 1.220 <0.0001 1·015 0.979, 1.051 0·43 1·398 1.078, 1.813 0·11
rs4065275 0·913 0.843, 0.989 0·026 1·054 1.003, 1.108 0·038 1·006 0.979, 1.035 0·65 0·962 0.786, 1.178 0·71
rs8076131 0·985 0.877, 1.105 0·79 1·225 1.144, 1.312 <0.0001 0·994 0.956, 1.034 0·78 1·328 0.998, 1.767 0·051